Novumed is often working on the forefront of future market developments. Many of our clients would like to forecast the opportunities or threats of new disruptive technologies and important trends. With the permission of our clients, Novumed publishes important results of these analysis or our own proprietary studies in our regular publication "Spotlight". These market insights are an important "food for thought", but we may of course not share the details of the strategies that have been developed together with our clients.
Latest Publications
 |
INDIA: From Global Supplier to Leading Consumer of Pharmaceutical Drugs30.01.2012
India, a nation of striking diversity, vast ambitions, and an even vaster manpower resource, is on the fast track to becoming a global economic superpower.
Recent census data depict a population growth of 17.64% between 2001 and 2011, and India is projected to be the world?s most populous country by 2025. With 1.25 billion people, India represents 17.5% of the world population as the 2nd most populated country in 2011.
Click here to order full publication, free of charge >> |
 |
Can big pharma's broken blockbuster strategy be cured by orphan drugs?31.10.2011
The blockbuster strategy of the pharmaceutical industry is challenged. The pharmaceutical industry has historically been spoiled by two-digit annual growth rates of around 11%. This trend ended in 2002, and according to market research data, the annual growth since then has decreased steadily to a mere 4% in 2010 over 2009. The impressive growth rates in the past were achieved by the industry's focus on blockbuster drugs, medicines that generate at least US$ 1 billion in annual sales.
Click here to order full publication, free of charge >> |
